It is worth noting that at advanced stages of renal impairment (CKD Stages 4–5), NTproBNP rises steeply highlighting the importance of looking at altering the NTproBNP thresholds based on co‐morbidities such as CKD. The gene discussed is NPPB; the disease is chronic kidney disease.